VE
Live / Allowed — Publication / registration review complete (as of 10 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79438380
- Mark type
- Design + words
- Filed
- 25 Aug 2025
- Published for opposition
- 29 Sept 2026
- Attorney of record
- Bruce Margulies
Goods and services
- Class 001 — Chemicals: Chemical compounds, namely, raw materials for use in the manufacture of cosmetics and pharmaceuticals, namely, ACS-Anticytostressor, Adf-Oleile, Afron-22, Afrosalt, Alcoramnosan, Alutrat, Aminoefaderma-20 N-P, Arrectosina, Auxina Tricogena, Azamide, Braxicina N-P, Carbossalina, Cellosan, Cetacene, Cetasol-Velvet, Collagenon, Dacriosalt, Daucoil N-P, Dermonectin, Delta Rosa Moschata, Desadrops, Efaderma, Efaderma-F, Efadermasterolo, Elicrisina, Epch, Fenexol, Filagrinol, Frabes-Oil Dcg, Hexatrate, Hexatrate Al-F, Hyaluramine-S, Hydrofarv, Idroramnosan, Integrine-60, Iodotrat, Ipbs-F, Isocet, Isostearene, Isoxal-1, Isoxal-12, Isoxal-H, Ixol-2, Ixol-4, Ixol-6, Ixol-8, Ixolene-2, Ixolene-4, Ixolene-6, Ixolene-8, Kalixide Grassa, Kalixide-As, Kalixide Ct, Keratoplast, Keresine P-E, Lanolide, Lanolide-Extra, Lanolide-F5, Lipocerite, Lipofarv, Lipogelag, Lipophos, Liporamnosan, Lipotrophyne-A, Liquiritina, Lmb, Megasol 3d, Megasol E-Sink, Megasol M-Mod, Melibion, Myristamine, Nesatol, Nidaba-318, Nidaba-S, Octaprotein-Colloid, Oligoidyne-1-Complex, Oligoidyne-2-Complex, Osmopherine, Osmopherone-H, Osmopherone-L, Phytosqual, Phytosqual Hydrogen, Pme, Pme-1 N-P, Poliglicoleum, Poliglicoleum-G, Poliglicoleum-N, Ricino-Viscoil-N, Salycuminol, Sebopessina, Seboside, Sitostene, Skyline-F, Skyline-P, Syntesqual, Talcoseptic-C, Tensoil-N, Tergene-12, Thalaton, Thalaton P-F, Tricosolfan, Trilipidina, Trioxene-Lv, Undamide, Undebenzofene-C, Undebenzofene-C P-F, Undebenzofene-Hp, Undelene, Undenat, Undezin, Vaselide, Viscolene, Visonoil-R, Vyox, Vyox-G, Xalidrene, Xalifin-15, Xalifin-15 N-P, Zedomine-1-L, Zedomine-2-L, Zedomine-3-L, Hydroessentials, Lipoplastidines; Surfactants for use in the manufacture of cosmetic finished products; Emulsifiers for use in the manufacture of cosmetic finished products; Fats and oils for use in the manufacture of cosmetic finished products; Rheologic Additives for use in manufacture of cosmetic finished products; Antioxidants for use in manufacture of cosmetic finished products; antioxidants for use in the manufacture of cosmetics; Preservatives for use in manufacture of cosmetic finished products; preservatives for use in the pharmaceutical industry; Inorganic and Metallorganic active chemical ingredients for use in manufacture of cosmetic finished products; iodine for chemical purposes; iodised salts for use in manufacture of cosmetic finished products; plant-derived active chemical ingredients for use in manufacture of cosmetic finished products; plant extracts for use in the manufacture of cosmetics; essential oils for use in manufacture; active chemical ingredients for use in manufacture of cosmetic finished products; Active chemical ingredients for use in manufacture of finished cosmetic products.
Owner
- MAGVIR s.r.l., IT
Prosecution history
- 04 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Sept 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 19 Aug 2026 — NOTIFICATION OF SUBSEQUENT FINAL EMAILED
- 19 Aug 2026 — CONTINUATION OF FINAL REFUSAL E-MAILED
- 19 Aug 2026 — ACTION CONTINUING A FINAL - COMPLETED
- 14 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Jul 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 14 May 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 14 May 2026 — FINAL REFUSAL E-MAILED
- 14 May 2026 — FINAL REFUSAL WRITTEN
- 06 Apr 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Apr 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE